May 10, 2018
The atopic dermatitis treatment Dupixent (dupilumab), an interleukin-4 receptor alpha antagonist, which was launched in April, should generally be used as an adjunctive therapy to topical drugs, said a dermatologist on May 8. According to Hidehisa Saeki, professor at Nippon...read more